Related Experiment Video
Updated: Jun 20, 2026

09:22
In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein
Published on: January 2, 2015
Investigating the Single-Fibril Growth Dynamics of Tau in a Heterogeneous Aggregation Landscape
Mahaprasad S R Sahu1, Maria Leslie Kannath2, Yann Fichou3
1Tata Institute of Fundamental Research, Hyderabad, Telangana 500046, India.
The Journal of Physical Chemistry. B
|March 3, 2026
Summary
Researchers discovered novel tau protein nanoaggregates, distinct from amyloid fibrils, which may seed tauopathies. These stable nanoaggregates form via electrostatic interactions and beta-sheet stabilization, potentially playing a key role in neurodegenerative disease progression.
Area of Science:
- Neuroscience
- Biochemistry
- Structural Biology
Background:
- Tau protein aggregation into distinct polymorphs is linked to specific tauopathies.
- Monitoring single aggregate formation is crucial for understanding tau aggregation mechanisms.
Purpose of the Study:
- To investigate the real-time formation and characteristics of tau aggregates in the presence of polyU RNA.
- To differentiate between nanoaggregate and fibril formation pathways and kinetics.
Main Methods:
- Total internal reflection fluorescence microscopy (TIRFM) for real-time monitoring.
- Electron microscopy and circular dichroism spectroscopy for structural analysis.
- Kinetic analysis of nucleation and growth rates.
Main Results:
- TIRFM revealed novel nanoaggregates alongside conventional amyloid fibrils.
- Nanoaggregates exhibit nucleation-dependent formation with slow growth (<20 nm/h), while fibrils show faster elongation (3-4 μm/h).
- Nanoaggregates are spherical (≈20 nm), beta-sheet rich, stable, and inhibited by salts, unlike fibrils.
Conclusions:
- Tau-polyanion nanoaggregates, stabilized by electrostatic, H-bonding, and hydrophobic interactions, may form intracellularly.
- These nanoaggregates could act as seeds for tau fibril proliferation in vivo.
- Understanding these distinct aggregation pathways is vital for tauopathy research.

